BT
biote Corp.
BTMD · NASDAQ
$1.33 -1.85% (-$0.03)
1M -15.29%
Market Cap $58.4M
P/E Ratio 9.98x
Div. Yield -
ROE -
Bulios Fair Price
$1.61
21.5% upside
Trenutna cena
$1.33
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BTMD trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
99 /100
Cheap P/E 9.98x
EV/EBITDA 7.50x
PEG 0.00x
Growth
71 /100
Growing EPS growth 66.61%
Rev. growth 5.23%
FCF growth N/A
Profitability
56 /100
Moderate Gross margin 60.23%
Net margin 3.19%
FCF margin 10.72%
Quality
75 /100
Excellent ROIC 13.50%
ROA 5.76%
Asset turnover 1.80x
Debt
26 /100
High Current ratio 1.43x
Int. coverage 2.10x
Net debt/EBITDA 5.01x
Stability
44 /100
Moderate Beta 1.61x
Rev. volatility 7.49%
Profitable years 3
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BTMD
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert C. Peterson
Employees
223
Headquarters
Irving
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report